Gustafsson J, Gunnarsson I, Börjesson O, Petterson S, Möller S, Guo-Zhong F, Elvin K, Simard JF, Hansson L-O, Lundberg IE, Larsson A, Svenungsson E: Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther. 2009, 11: R186-10.1186/ar2878.
Article
PubMed Central
PubMed
Google Scholar
Toloza SM, Uribe AG, McGwin G, Alarcón GS, Fessler BJ, Bastian HM, Vilá LM, Wu R, Shoenfeld Y, Roseman JM, Reveille JD, for the LUMINA Study Group: Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum. 2004, 50: 3947-3957. 10.1002/art.20622.
Article
PubMed
Google Scholar
Mok CC, Tang SS, To CH, Petri M: Incidence and risk factors of thromboembolism in systemic lupus erythematosus. A comparison of three ethnic groups. Arthritis Rheum. 2005, 52: 2774-2782. 10.1002/art.21224.
Article
PubMed
Google Scholar
Urowitz MB, Ibanez D, Gladman DD: Atherosclerotic vascular events in a single large lupus cohort: Prevalence and risk factors. J Rheumatol. 2007, 34: 70-75.
PubMed
Google Scholar
Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae S-C, Isenberg D, Zoma A, Aranow C, Dooley M-A, Nived O, Sturfelt G, Steinsson K, Alarcón G, Senécal J-L, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, et al: Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006, 54: 2550-2557. 10.1002/art.21955.
Article
CAS
PubMed
Google Scholar
Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côté R, Grover SA, Fortin PR, Clarke A, Senécal J-L: Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001, 44: 2331-2337. 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I.
Article
CAS
PubMed
Google Scholar
Spiel AO, Gilbert JC, Jilma B: Von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008, 117: 1449-1459. 10.1161/CIRCULATIONAHA.107.722827.
Article
CAS
PubMed
Google Scholar
de Leeuw K, Freire B, Smit AJ, Bootsma H, Kallenberg CG, Bijl M: Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. Lupus. 2006, 15: 675-682. 10.1177/0961203306069972.
Article
CAS
PubMed
Google Scholar
Lindsey NJ, Dawson RA, Henderson FI, Greaves M, Hughes P: Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis prone patients with systemic lupus erythematosus and the anti-phospholipid syndrome. Br J Rheumatol. 1993, 32: 123-126. 10.1093/rheumatology/32.2.123.
Article
CAS
PubMed
Google Scholar
Lai KN, Leung JCK, Lai KB, Lai FM, Wong KC: Increased release of von Willebrand factor antigen from endothelial cells by anti-DNA autoantibodies. Ann Rheum Dis. 1996, 55: 57-62. 10.1136/ard.55.1.57.
Article
PubMed Central
CAS
PubMed
Google Scholar
Petri M: The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort. Thromb Res. 2004, 114: 593-595. 10.1016/j.thromres.2004.07.012.
Article
CAS
PubMed
Google Scholar